cefoperazone has been researched along with Health Care Associated Infection in 39 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 9 (23.08) | 18.7374 |
1990's | 6 (15.38) | 18.2507 |
2000's | 9 (23.08) | 29.6817 |
2010's | 10 (25.64) | 24.3611 |
2020's | 5 (12.82) | 2.80 |
Authors | Studies |
---|---|
Caniça, M; Ferreira, E; Leitão, J; Manageiro, V; Mendonça, N | 1 |
Fang, X; Huang, F; Wang, J; Yu, J | 1 |
Han, Z; Shen, S; Xiong, Z; Zeng, D | 1 |
Guclu, E; Karabay, O; Kaya, G; Ogutlu, A | 1 |
Aggarwal, A; Sahu, C; Thomas, KN | 1 |
Cao, J; Chen, L; Liao, W; Xu, W; Xu, Y; Yu, K; Zeng, W; Zhou, T | 1 |
Hao, D; Hu, Z; Liu, X; Sun, T; Tian, H; Wang, T; Wang, X | 1 |
Li, J; Ma, W; Sun, S; Wang, D; Yu, C | 1 |
Li, Z; Liu, S; Sun, CD; Wang, Y | 1 |
Bosnak, VK; Karaoglan, I; Mete, AO; Namiduru, M; Zer, Y | 1 |
Fang, X; Gong, M; Xia, J; Xu, Y; Zhang, D; Zhou, Y | 1 |
Arslan, U; Kus, H; Tuncer, I; Turk Dagi, H | 1 |
Herych, ID; Vashchuk, VV | 1 |
Aktas, A; Divrikli, D; Gursoy, T; Ovali, F; Sari, I | 1 |
Altın, N; Argun, C; Canbakan, B; Cesur, S; Koldaş, K; Kurşun, O; Sencan, I; Unal, N | 1 |
Du, W; Liu, Y; Rui, X; Shi, Y; Wang, Y; Xu, YC | 1 |
Blahová, J; Jezek, P; Králiková, K; Krćméry, V; Vaculíková, A | 1 |
Chen, P; Cheng, WC; Xiang, XD; Zan, JN | 1 |
Chen, MJ; Wang, H | 1 |
Mitrokhin, SD | 1 |
Bachinskaia, EN; Beloborodova, NV; Kuznetsova, ST; Popov, DA; Vostrikov, TIu | 1 |
Das, BK; Dhawan, B; Kapil, A; Mohanty, S; Singhal, R; Sood, S | 1 |
Cherkashin, EA; Galeeva, EV; Ivanov, DV; Krapivina, IV; Sidorenko, SV; Veshutova, NS | 1 |
Ernest, KD; Magnussen, CR; Sammartino, MT | 1 |
Jones, RN | 1 |
Barranco, SF; Cohen, MS; Washton, HE | 1 |
Croce, MA; Fabian, TC; Kudsk, KA; Minard, G; Pritchard, FE; Stewart, RM; Trenthem, L | 1 |
Branaman-Phillips, J; Phillips, SL | 1 |
Cheong, YM; Lim, VK | 1 |
Iakovlev, VP | 1 |
Andriole, VT; Berenson, C; Greco, T; Mangi, RJ; Peccerillo, KM; Ryan, J; Thornton, G | 1 |
Breitenbucher, RB | 1 |
Durgham, SM; Ishag, AH; Shibl, AM | 1 |
Albano, O; Malvestiti, FM; Monno, D; Morelli, N; Palasciano, G; Tardi, S; Velardi, A | 1 |
Andriole, VT; Berenson, C; Greco, T; Mangi, RJ; Ryan, J; Simms, M; Thornton, G | 1 |
Andriole, VT; Greco, T; Mangi, RJ; Ryan, J; Thornton, G | 1 |
Chelluri, L | 1 |
Guenthner, SH; Norris, SM; Wenzel, RP | 1 |
2 review(s) available for cefoperazone and Health Care Associated Infection
Article | Year |
---|---|
[Modern possibilities of hepacef combi (cefoperazon/sulbactam) application for the treatment of surgical infection].
Topics: Anti-Bacterial Agents; Cefoperazone; Cross Infection; Drug Combinations; Humans; Sulbactam; Surgical Wound Infection | 2011 |
[Analysis of the 10-year use in Russia of cefoperazone, a third-generation cefalosporin, in the treatment of hospital infections].
Topics: Adult; Cefoperazone; Cephalosporins; Child; Cross Infection; Economics, Pharmaceutical; Follow-Up Studies; Humans; Infant, Newborn; Microbial Sensitivity Tests; Russia; Treatment Outcome | 1999 |
6 trial(s) available for cefoperazone and Health Care Associated Infection
Article | Year |
---|---|
Multicenter clinical trial of cefoperazone sodium in the United States.
Topics: Aged; Bacterial Infections; Cefoperazone; Clinical Trials as Topic; Cross Infection; Drug Administration Schedule; Female; Genital Diseases, Female; Humans; Male; Middle Aged; Osteomyelitis; Respiratory Tract Infections; Sepsis; Skin Diseases, Infectious; United States; Urinary Tract Infections | 1984 |
Empiric monotherapy versus combination therapy of nosocomial pneumonia in trauma patients.
Topics: Adolescent; Adult; Aged; Cefoperazone; Ceftazidime; Cross Infection; Drug Therapy, Combination; Female; Gentamicins; Hospital Mortality; Humans; Incidence; Infusions, Intravenous; Injury Severity Score; Male; Methicillin Resistance; Microbial Sensitivity Tests; Middle Aged; Pneumonia; Prospective Studies; Staphylococcal Infections; Superinfection; Wounds, Nonpenetrating; Wounds, Penetrating | 1993 |
The use of intramuscular cefoperazone versus intramuscular ceftriaxone in patients with nursing home-acquired pneumonia.
Topics: Aged; Aged, 80 and over; Bacterial Infections; Cefoperazone; Ceftriaxone; Cross Infection; Female; Humans; Injections, Intramuscular; Male; Nursing Homes; Pneumonia | 1993 |
Cefoperazone versus ceftriaxone monotherapy of nosocomial pneumonia.
Topics: Adult; Aged; Aged, 80 and over; Cefoperazone; Ceftriaxone; Costs and Cost Analysis; Cross Infection; Female; Humans; Male; Middle Aged; Pneumonia; Prospective Studies; Sputum; Superinfection | 1992 |
Cefoperazone versus ceftazidime monotherapy of nosocomial pneumonia.
Topics: Bacteria; Bacterial Infections; Cefoperazone; Ceftazidime; Clinical Trials as Topic; Costs and Cost Analysis; Cross Infection; Humans; Pneumonia; Prospective Studies; Random Allocation; Sputum | 1988 |
Cefoperazone versus combination antibiotic therapy of hospital-acquired pneumonia.
Topics: Anti-Bacterial Agents; Cefazolin; Cefoperazone; Clindamycin; Clinical Trials as Topic; Costs and Cost Analysis; Cross Infection; Drug Therapy, Combination; Gentamicins; Humans; Hypoprothrombinemias; Pneumonia; Prospective Studies; Random Allocation | 1988 |
31 other study(ies) available for cefoperazone and Health Care Associated Infection
Article | Year |
---|---|
Spread of extended-spectrum beta-lactamase CTX-M-producing escherichia coli clinical isolates in community and nosocomial environments in Portugal.
Topics: Aged; Anti-Bacterial Agents; beta-Lactamases; Community-Acquired Infections; Cross Infection; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Humans; Microbial Sensitivity Tests; Middle Aged; Portugal | 2007 |
Investigation and Analysis of Infection among Inpatients in a Tertiary Hospital in Shanghai.
Topics: Adult; Anti-Bacterial Agents; Cefoperazone; China; Community-Acquired Infections; Cross Infection; Drug Resistance, Bacterial; Humans; Inpatients; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Retrospective Studies; Sulbactam; Tertiary Care Centers | 2022 |
The Investigation on Nosocomial Infection of Acinetobacter baumannii and the Clinical Analysis of Sequential Therapy of Cefoperazone/Sulbactam Sodium for Intracranial Infection.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Case-Control Studies; Cefoperazone; Cross Infection; Humans; Retrospective Studies; Sodium; Sulbactam; Tigecycline | 2022 |
The effect of cefoperazone sulbactam and piperacillin tazobactam on mortality in Gram-negative nosocomial infections.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Cefoperazone; Cross Infection; Drug Combinations; Drug Resistance, Multiple, Bacterial; Female; Gram-Negative Bacterial Infections; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Sulbactam | 2020 |
Ralstonia mannitolilytica bacteraemia and gastroenteritis in a patient with rheumatoid arthritis: an emerging nosocomial infection.
Topics: Anti-Bacterial Agents; Arthritis, Rheumatoid; Bacteremia; Cefoperazone; Cross Infection; Diarrhea; Female; Gastroenteritis; Gram-Negative Bacterial Infections; Humans; Middle Aged; Ralstonia; Sulbactam | 2021 |
Bloodstream infections caused by ST2 Acinetobacter baumannii: risk factors, antibiotic regimens, and virulence over 6 years period in China.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cefoperazone; China; Cross Infection; Drug Resistance, Multiple, Bacterial; Female; Hospital Mortality; Humans; Intensive Care Units; Male; Microbial Sensitivity Tests; Middle Aged; Respiration, Artificial; Retrospective Studies; Risk Factors; Sepsis; Sulbactam; Thrombocytopenia; Tigecycline; Virulence; Young Adult | 2021 |
[Analysis of the distribution characteristics and drug resistance of non-fermenting bacterial infection in intensive care unit from 2009 to 2015]
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Bacterial Infections; Cefepime; Cefoperazone; Cephalosporins; Cross Infection; Drug Resistance; Drug Resistance, Bacterial; Gram-Negative Bacteria; Humans; Imipenem; Intensive Care Units; Meropenem; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Retrospective Studies; Thienamycins | 2016 |
In vitro interaction of various antibiotic combinations recommended by Chinese consensus statement against carbapenems-resistant Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; Aztreonam; Carbapenems; Cefoperazone; Ceftazidime; China; Cross Infection; Drug Resistance, Bacterial; Drug Therapy, Combination; Humans; Microbial Sensitivity Tests; Piperacillin; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam | 2019 |
[Drug resistance analysis of pan-drug-resistant Acinetobacter baumannii in hospital].
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Cefoperazone; Cross Infection; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests | 2013 |
In vitro synergistic activity of colistin with tigecycline or β-lactam antibiotic/β-lactamase inhibitor combinations against carbapenem-resistant Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamase Inhibitors; Carbapenems; Cefoperazone; Colistin; Cross Infection; Drug Resistance, Multiple, Bacterial; Drug Synergism; Humans; Microbial Sensitivity Tests; Minocycline; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sulbactam; Tigecycline | 2013 |
A retrospective analysis of carbapenem-resistant Acinetobacter baumannii-mediated nosocomial pneumonia and the in vitro therapeutic benefit of cefoperazone/sulbactam.
Topics: Acinetobacter baumannii; Aged; Aged, 80 and over; Anti-Bacterial Agents; C-Reactive Protein; Carbapenems; Cefoperazone; Cross Infection; Drug Combinations; Drug Resistance, Multiple, Bacterial; Drug Synergism; Female; Humans; Levofloxacin; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Minocycline; Pneumonia, Bacterial; Retrospective Studies; Sulbactam; Thienamycins | 2014 |
[In vitro synergistic activity of sulbactam in combination with imipenem, meropenem and cefoperazone against carbapenem-resistant Acinetobacter baumannii isolates].
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Cefoperazone; Cross Infection; Drug Combinations; Drug Synergism; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Sulbactam; Thienamycins | 2014 |
Use of cefoperazone/sulbactam in neonates.
Topics: Anti-Bacterial Agents; Bacterial Infections; Cefoperazone; Cross Infection; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Humans; Infant, Newborn; Male; Microbial Sensitivity Tests; Sulbactam | 2012 |
[A case of ventilator-associated pneumonia due to Pantoea agglomerans].
Topics: Anti-Bacterial Agents; Cefoperazone; Cross Infection; Drug Therapy, Combination; Enterobacteriaceae Infections; Heart Arrest; Humans; Kidney Failure, Chronic; Male; Middle Aged; Ofloxacin; Opportunistic Infections; Pantoea; Pneumonia, Ventilator-Associated; Respiration, Artificial; Sulbactam | 2012 |
[Cefoperazone-sulbactam plus minocycline in the treatment of extensively drug resistant Acinetobacter infections].
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Aged, 80 and over; Cefoperazone; Cross Infection; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Minocycline; Prospective Studies; Sulbactam | 2012 |
First occurrence of transferable extended-spectrum beta-lactamase hydrolyzing cefoperazone in multiresistant nosocomial strains of Klebsiella pneumoniae from two hospitals in Czech and Slovak Republics.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Cefoperazone; Cephalosporins; Cross Infection; Czech Republic; Drug Interactions; Drug Resistance, Multiple; Escherichia coli; Humans; Hydrolysis; Klebsiella Infections; Klebsiella pneumoniae; Proteus mirabilis; Slovakia | 2002 |
[Distribution of bacteria and analysis of their sensibility to antibiotics in patients with hospital-acquired pneumonia].
Topics: Adult; Aged; Aged, 80 and over; Cefoperazone; Ceftriaxone; Cross Infection; Female; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Pneumonia, Bacterial; Pseudomonas aeruginosa; Pseudomonas Infections; Staphylococcal Infections; Staphylococcus epidermidis | 2000 |
[Changes of antimicrobial resistance among nonfermenting gram-negative bacilli isolated from intensive care units from 1994 to 2001 in China].
Topics: Anti-Bacterial Agents; Cefoperazone; Cross Infection; Drug Resistance, Microbial; Gram-Negative Bacteria; Humans; Intensive Care Units; Microbial Sensitivity Tests; Piperacillin; Pseudomonas aeruginosa; Sulbactam | 2003 |
[Sulperazone in the treatment of severe infections in patients with cancer].
Topics: Anti-Bacterial Agents; Cefoperazone; Cross Infection; Drug Combinations; Drug Therapy, Combination; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Neoplasms; Pneumonia, Bacterial; Sulbactam; Surgical Wound Infection; Urinary Tract Infections | 2003 |
[Clinical experience with the treatment of severe nosocomial infections by inhibitor-protected 3rd generation cephalosporin cefoperazone/sulbactam].
Topics: Adult; Anti-Bacterial Agents; Cefoperazone; Child; Child, Preschool; Cross Infection; Drug Combinations; Gram-Negative Bacteria; Humans; Infant; Male; Middle Aged; Postoperative Complications; Sulbactam | 2005 |
Comparative in vitro activity of beta-lactam/beta-lactamase inhibitor combinations against gram negative bacteria.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamase Inhibitors; Cefoperazone; Clavulanic Acids; Cross Infection; Gram-Negative Bacteria; Humans; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sulbactam; Ticarcillin | 2005 |
[Three-year experience with the use of cefoperazone/sulbactam (sulperazone) in the treatment of hospital-acquired infections in an oncologic hospital].
Topics: Anti-Infective Agents; Candida; Cefoperazone; Cross Infection; Drug Combinations; Drug Resistance, Microbial; Drug Therapy, Combination; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Oncology Service, Hospital; Sulbactam | 2006 |
[Resistance epidemiology of gramnegative nonfermenting pathogens of nosocomial infections in intensive care units and surgical departments].
Topics: Acinetobacter baumannii; Adolescent; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cefoperazone; Child; Child, Preschool; Cross Infection; Drug Resistance, Microbial; Genes, Bacterial; Gram-Negative Bacterial Infections; Humans; Infant; Intensive Care Units; Microbial Sensitivity Tests; Molecular Epidemiology; Moscow; Pseudomonas aeruginosa; Sulbactam; Surgery Department, Hospital | 2006 |
Aminoglycoside-resistant gram-negative bacilli in a community hospital: comparative in vitro activity of cefotaxime, moxalactam, cefoperazone, and piperacillin.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacteria; Cefoperazone; Cefotaxime; Cephalosporins; Cephamycins; Cross Infection; Humans; Moxalactam; Penicillin Resistance; Penicillins; Piperacillin | 1982 |
Changing patterns of resistance to new beta-lactam antibiotics. In vitro efficacy of cefoperazone against bacterial pathogens.
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; beta-Lactamases; Cefoperazone; Cross Infection; Drug Interactions; Drug Resistance, Microbial; Drug Therapy, Combination; Enterobacteriaceae; Humans; Hydrolysis; Microbial Sensitivity Tests | 1984 |
In-vitro activity of cefoperazone-sulbactam combination against cefoperazone resistant clinical isolates in a Malaysian general hospital.
Topics: Cefoperazone; Cephalosporin Resistance; Cross Infection; Drug Combinations; Gram-Negative Bacterial Infections; Hospitals, General; Malaysia; Sulbactam | 1995 |
UTI: managing the most common nursing home infection.
Topics: Activities of Daily Living; Aged; Cefoperazone; Ciprofloxacin; Cross Infection; Female; Homes for the Aged; Humans; Hygiene; Male; Nursing Homes; Prevalence; Risk Factors; Sex Factors; Urinary Catheterization; Urinary Tract Infections | 1990 |
Comparative in vitro antibacterial activity of aztreonam against clinical isolates of gram-negative bacteria.
Topics: Aztreonam; Cefoperazone; Cefotaxime; Ceftazidime; Cross Infection; Gentamicins; Gram-Negative Bacteria; Moxalactam; Ticarcillin | 1989 |
[Efficacy and tolerability of cefoperazone in patients with nosocomial infections].
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Cefoperazone; Cholecystitis; Cross Infection; Drug Evaluation; Drug Tolerance; Female; Humans; Male; Middle Aged; Respiratory Tract Infections; Skin Diseases, Infectious; Time Factors; Tonsillitis; Urinary Tract Infections | 1988 |
Cefoperazone versus combination antibiotic therapy of hospital-acquired pneumonia.
Topics: Anti-Bacterial Agents; Cefoperazone; Cross Infection; Drug Therapy, Combination; Humans; Pneumonia | 1988 |
Comparative activity of seven extended-spectrum cephalosporins against gram-negative bacilli from blood cultures.
Topics: Cefmenoxime; Cefoperazone; Cefotaxime; Ceftazidime; Ceftizoxime; Ceftriaxone; Cephalosporins; Cross Infection; Enterobacteriaceae; Enterobacteriaceae Infections; Gram-Negative Bacteria; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Sepsis | 1985 |